玮俊生物科技(00660)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00660 玮俊生物科技

未开盘 08-25 15:00:16

0.430

+0.030

+7.50%

最高0.430	最低0.430	成交量5.00万
今开0.430	昨收0.400	日振幅0.00%
总市值1.65亿	流通市值1.65亿	总股本3.84亿
成交额2.16万	换手率0.01%	流通股本3.84亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00660","market":"HK","secType":"STK","nameCN":"玮俊生物科技","latestPrice":0.43,"timestamp":1787641216062,"preClose":0.4,"halted":0,"volume":50000,"delay":0,"changeRate":0.07499999999999993,"floatShares":384000000,"shares":384000000,"eps":-0.084305,"marketStatus":"未开盘","change":0.03,"latestTime":"08-25 15:00:16","open":0.43,"high":0.43,"low":0.43,"amount":21600,"amplitude":0,"askPrice":0.41,"askSize":20000,"bidPrice":0.37,"bidSize":20000,"shortable":0,"etf":0,"ttmEps":-0.018,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787707800000},"marketStatusCode":0,"adr":0,"listingDate":728841600000,"exchange":"SEHK","adjPreClose":0.4,"openAndCloseTimeList":[[1787621400000,1787630400000],[1787634000000,1787644800000]],"volumeRatio":0.943396,"lotSize":20000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00660","defaultTab":"news","newsList":[{"id":"1189841877","title":"玮俊生物科技(00660)签署马来西亚彭亨州航空城AI数据中心等项目战略合作谅解备忘录","url":"https://stock-news.laohu8.com/highlight/detail?id=1189841877","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189841877?lang=zh_cn&edition=full","pubTime":"2026-08-25 23:02","pubTimestamp":1787670124,"startTime":"0","endTime":"0","summary":"2026年8月25日，玮俊生物科技有限公司公告称，公司已与Pahang Aerospace City Development Berhad、Baiyuzen Holdings Sdn Bhd、Ennova ICT Pte Ltd及Radiant  Holdings Limited签订关于马来西亚彭亨州航空城综合AI数字基建生态系统项目的战略合作谅解备忘录。谅解备忘录除保密、排他性谈判期、合规及管辖法律等条款外，其商业条款不具法律约束力，项目实施仍需各方进一步评估并签订正式协议。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108837137","title":"玮俊生物科技2026年7月股份变动月报表，总股本增至384,309,785股","url":"https://stock-news.laohu8.com/highlight/detail?id=1108837137","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108837137?lang=zh_cn&edition=full","pubTime":"2026-08-06 16:41","pubTimestamp":1786005698,"startTime":"0","endTime":"0","summary":"2026年8月6日，玮俊生物科技有限公司发布2026年7月股份变动月报表。公告显示，公司普通股法定股本数为10,000,000,000股，每股面值为0.01港元，对应法定股本1亿港元；可换股优先股法定股本数为204,000,000股，每股面值为0.01港元，对应法定股本204万港元。截至7月末，玮俊生物科技公司法定股本总额为1.0204亿港元。报告期内，普通股已发行股本由367,643,119股增至384,309,785股，新增16,666,666股。根据此次月报，公司已发行股份及股本整体保持稳定，期末普通股股数为384,309,785股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146046205","title":"玮俊生物科技获全球起重机与矿山设备独家海外总代理权","url":"https://stock-news.laohu8.com/highlight/detail?id=1146046205","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146046205?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:33","pubTimestamp":1785940388,"startTime":"0","endTime":"0","summary":"玮俊生物科技（Wai Chun Bio Technology）——正式被委任为全球范围内起重设备与矿山机械的独家海外总代理。这一授权标志着该公司在工程机械领域拓展了全新业务版图，从生物科技领域跨界至重型设备分销。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1237","00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116157371","title":"玮俊生物科技：7月7日可换股债券转股1666.67万股，占比4.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116157371","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116157371?lang=zh_cn&edition=full","pubTime":"2026-07-07 17:34","pubTimestamp":1783416843,"startTime":"0","endTime":"0","summary":"玮俊生物科技（股票代码：00660）于2026年7月7日发布公告，披露公司完成一笔金额为100万港元的可换股债券转股，并按每股0.01港元的发行价格增发16,666,666股普通股，折合约1666.67万股，占本次发行前公司已发行股本的4.53%。\n本次增发完成后，公司已发行股本由原先的367,643,119股增至384,309,785股，库藏股份数保持为零。公告显示，此次发行已获公司董事会正式授权，并遵循了香港联合交易所证券上市规则及相关法律法规。公告最后由董事林家俊签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"玮俊生物科技：7月7日可换股债券转股1666.67万股，占比4.53%","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649985782","title":"玮俊生物科技(00660.HK)因可换股债券获转换而发行1666.67万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649985782","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649985782?lang=zh_cn&edition=full","pubTime":"2026-07-07 17:30","pubTimestamp":1783416627,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00660","BK1237"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649498578","title":"玮俊生物科技(00660)因可换股债券获转换而发行1666.67万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649498578","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649498578?lang=zh_cn&edition=full","pubTime":"2026-07-07 17:30","pubTimestamp":1783416627,"startTime":"0","endTime":"0","summary":"智通财经APP讯，玮俊生物科技(00660)发布公告，于2026年7月7日，该公司金额为100万港元的可换股债券以每股0.01港元转换及发行1666.67万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00660","BNDW","BK1237"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137130826","title":"玮俊生物科技更新2026年6月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1137130826","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137130826?lang=zh_cn&edition=full","pubTime":"2026-07-07 16:46","pubTimestamp":1783414009,"startTime":"0","endTime":"0","summary":"玮俊生物科技有限公司于2026年7月7日发布了截至2026年6月30日的证券变动月报表。报告显示，报告期内公司股本保持稳定，没有新增发行、购回或注销股份的活动。普通股及可换股优先股在本报告期内未发生增减变动。截至2026年6月30日，普通股实发股本为367,643,119股，与上月持平；优先股以204,000,000股的数量维持不变。公司合计已发行股份无变化，并确认其公开持股量符合香港联交所上市规则的规定。本次月报由执行董事林家俊签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169368534","title":"玮俊生物科技公布2026年5月股份变动月报表：当月增发22,500,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1169368534","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169368534?lang=zh_cn&edition=full","pubTime":"2026-06-03 14:41","pubTimestamp":1780468877,"startTime":"0","endTime":"0","summary":"玮俊生物科技有限公司于2026年6月3日发布2026年5月股份变动月报表。截至2026年5月31日，公司法定注册股本维持在港币102,040,000，其中普通股10,000,000,000股、可换股优先股204,000,000股，面值均为港币0.01。报告期内，普通股已发行股份由345,143,119股增至367,643,119股，增加22,500,000股，无库存股变动。根据月报，购股权计划项下的股份期权在本月无新股发行，结存的股份期权数量保持15,954,685份，行使价为每股港币0.25。此外，公司本月未进行任何股份回购或注销活动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635577692","title":"机器人板块逆市走高 卧龙安机器人(06600)涨9.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635577692","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635577692?lang=zh_cn&edition=full","pubTime":"2026-05-15 10:57","pubTimestamp":1778813839,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股机器人板块逆市走高，卧龙安机器人  涨 9.26%，兆威机电  涨 9.01%，埃斯顿  涨 8.62%，蓝思科技  涨 6.67%，三花智控  涨 4.46%，优必选  涨 4.11%，极智嘉W  涨 3.64%。消息面上，全国首部具身智能机器人领域地方性法规《杭州市促进具身智能机器人产业发展条例》正式施行，标志着机器人产业从技术探索迈向规范化发展阶段。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/NTRmYzVmNDdmYzg0MjRhYWE5NzljZDI3ZDUxMDYzNjE2NzY4MDQ=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NTRmYzVmNDdmYzg0MjRhYWE5NzljZDI3ZDUxMDYzNjE2NzY4MDQ=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981425","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1613","02715","LU0348766576.USD","SG9999011746.SGD","BK1183","002747","BK1191","LU0348767384.USD","LU0082770016.SGD","BK1170","LU0164939612.USD","09880","003021","02050","300433","BK1214","02590","002050","00660","BK1116","LU0620787316.HKD","06613","LU0082770016.USD","LU0274383008.USD","02692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635572097","title":"玮俊生物科技(00660)股东将股票存入马银证券(香港) 存仓市值2002.50万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2635572097","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635572097?lang=zh_cn&edition=full","pubTime":"2026-05-15 08:11","pubTimestamp":1778803902,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月14日，玮俊生物科技(00660)股东将股票存入马银证券(香港)，存仓市值2002.50万港元，占比6.12%。此前玮俊生物科技发布公告，于2026年5月5日，该公司根据金额为135万港元的可换股债券以每股0.01港元转换及发行2250万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442002.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161027","00660","BK1237"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115681901","title":"玮俊生物科技：5月5日发行22,500,000股股份 占原股本6.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=1115681901","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115681901?lang=zh_cn&edition=full","pubTime":"2026-05-05 18:43","pubTimestamp":1777977780,"startTime":"0","endTime":"0","summary":"2026年5月5日，玮俊生物科技有限公司（00660）发布公告，披露通过转换金额为1,350,000港元的可换股债券，以每股0.01港元的价格发行22,500,000股新股。该批新增股份占转换前公司已发行股份（345,143,119股）的约6.52%。\n本次发行完成后，公司已发行股本由345,143,119股增至367,643,119股，库藏股数量保持为0。公司声明已按所有适用的上市规则及相关法律规定办理本次股份发行事宜。\n公告由董事林家俊签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"玮俊生物科技：5月5日发行22,500,000股股份 占原股本6.52%","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633919407","title":"玮俊生物科技(00660)因可换股债券获转换而发行2250万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2633919407","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633919407?lang=zh_cn&edition=full","pubTime":"2026-05-05 18:38","pubTimestamp":1777977488,"startTime":"0","endTime":"0","summary":"智通财经APP讯，玮俊生物科技(00660)发布公告，于2026年5月5日，该公司根据金额为135万港元的可换股债券以每股0.01港元转换及发行2250万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438173.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BNDW","00660","BK1237"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132675275","title":"玮俊生物科技发布2026年4月股份变动月报表，股本有所扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=1132675275","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132675275?lang=zh_cn&edition=full","pubTime":"2026-05-04 13:25","pubTimestamp":1777872349,"startTime":"0","endTime":"0","summary":"玮俊生物科技有限公司于2026年5月4日发布2026年4月股份变动月报表，显示截至2026年4月30日，公司已发行普通股数量由上月底的178,476,453股增加至345,143,119股，新增166,666,666股，股本规模有所扩大。公司在公告中确认，截至2026年4月30日，其已满足适用的公众持股量要求。同时，公告提及所有增发及转让相关事宜均严格遵守《香港联合交易所有限公司证券上市规则》和相关法律法规的规定。公告由执行董事林家俊签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630391763","title":"玮俊生物科技(00660)因可换股债券获转换而发行1.67亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2630391763","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2630391763?lang=zh_cn&edition=full","pubTime":"2026-04-27 20:56","pubTimestamp":1777294601,"startTime":"0","endTime":"0","summary":"智通财经APP讯，玮俊生物科技(00660)发布公告，于2026年4月27日，该公司根据金额为1000万港元的可换股债券以每股0.01港元转换及发行1.67亿股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434714.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BNDW","00660","BK1237"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194089182","title":"玮俊生物科技：可换股债券转股发行1.6667亿股，占已发行股本约93.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194089182","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194089182?lang=zh_cn&edition=full","pubTime":"2026-04-27 20:55","pubTimestamp":1777294551,"startTime":"0","endTime":"0","summary":"玮俊生物科技(股票代码：00660)于2026年4月27日发布公告，称公司因可换股债券转股而新增发行普通股股份。根据公告，此次发行基于本金为1,000万港元的可换股债券，以每股0.01港元的价格进行转股，涉及166,666,666股普通股，占此前已发行股本约93.38%。\n公告显示，本次股本变动后，公司已发行普通股总数增至345,143,119股，库藏股仍维持为零。公司确认此次发行已获董事会正式授权，并遵守香港联交所证券上市规则及相关法律规定。\n该公告由公司董事林家俊签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"玮俊生物科技：可换股债券转股发行1.6667亿股，占已发行股本约93.38%","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627928392","title":"陈冠宇减持玮俊生物科技(00660)64万股 每股均价1.80港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627928392","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2627928392?lang=zh_cn&edition=full","pubTime":"2026-04-16 18:57","pubTimestamp":1776337028,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据香港联交所最新数据显示，4月14日，陈冠宇减持玮俊生物科技(00660)64万股，每股均价1.80港元，总金额为115.2万港元。减持后最新持股数目约为4136.31万股，持股比例为23.18%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429503.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00660","EWH","BK1237"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627471622","title":"港股异动 | 玮俊生物科技(00660)回落超40% 日前披露新能源大计股价暴涨8倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2627471622","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2627471622?lang=zh_cn&edition=full","pubTime":"2026-04-15 10:20","pubTimestamp":1776219635,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，玮俊生物科技回落超40%，该股昨日复牌大涨，最终收涨超800%。截至发稿，跌40.87%，报1.36港元，成交额2109.48万港元。消息面上，玮俊生物科技日前公布，4月12日，公司作为总牵头方及控股方，与多家中国大型央企、海外知名跨国巨头及国际顶级金融机构联合签署了《新能源项目战略合作备忘录》。合作各方将在全球范围内共同投资、开发、建设和运营风力及太阳能发电等新能源项目。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1428640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1237","BK4588","000941.SH","399941","00660","BK4585","159875","160640","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627467767","title":"玮俊生物科技公布将于4月14日上午起复牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2627467767","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2627467767?lang=zh_cn&edition=full","pubTime":"2026-04-14 08:58","pubTimestamp":1776128280,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　玮俊生物科技（00660）发布公告，该公司股份将于2026年4月14日上午9时正起恢复买卖。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-04-14/doc-inhummye5010460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1237","00660"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627737433","title":"玮俊生物科技(00660)与大型央企及国际巨头强强联合 签署《新能源项目战略合作备忘录》","url":"https://stock-news.laohu8.com/highlight/detail?id=2627737433","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2627737433?lang=zh_cn&edition=full","pubTime":"2026-04-13 16:37","pubTimestamp":1776069469,"startTime":"0","endTime":"0","summary":"智通财经APP讯，玮俊生物科技 公布，于2026年4月12日，该公司作为总牵头方及控股方，与多家中国大型央企(央企)、海外知名跨国巨头及国际顶级金融机构联合签署了《新能源项目战略合作备忘录》。合作各方将成立由公司牵头的联合工作组，定期召开推进会并锁定项目资源。董事会认为，本次战略合作备忘录的签署，是集团发展史上的最重大里程碑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1427723.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159875","00660","BK1237","399941","000941.SH","160640"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156166472","title":"玮俊生物科技锁定全球九大市场：泰国、印尼、中亚、美加、罗马尼亚、沙特、赞比亚、蒙古","url":"https://stock-news.laohu8.com/highlight/detail?id=1156166472","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156166472?lang=zh_cn&edition=full","pubTime":"2026-04-13 16:37","pubTimestamp":1776069429,"startTime":"0","endTime":"0","summary":"玮俊生物科技正加速推进其全球化战略布局，计划将业务版图拓展至包括泰国、印度尼西亚在内的东南亚市场，并同步进军中亚地区。与此同时，北美市场的美国与加拿大、欧洲的罗马尼亚、中东的沙特阿拉伯，以及非洲的赞比亚和东亚的蒙古，均被纳入其重点目标区域。这一系列举措彰显了公司打造跨国产业链的决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1237","00660"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.0660.hk","stockEarnings":[{"period":"1week","weight":0.0361},{"period":"1month","weight":0},{"period":"3month","weight":-0.4028},{"period":"6month","weight":0.6538},{"period":"1year","weight":1.0673},{"period":"ytd","weight":1.2872}],"compareEarnings":[{"period":"1week","weight":0.0016},{"period":"1month","weight":0.0219},{"period":"3month","weight":0.0072},{"period":"6month","weight":-0.033},{"period":"1year","weight":-0.0123},{"period":"ytd","weight":-0.0047}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"玮俊生物科技有限公司是一家主要从事制造及销售变性淀粉的香港投资控股公司。该公司连同其附属公司主要从事制造及销售变性淀粉及其他生化产品,例如生化精炼油产品。此外，该公司还从事买卖电子元件、组件和器件及电器。","yearOnYearQuotes":[{"month":1,"riseRate":0.393939,"avgChangeRate":0.06724},{"month":2,"riseRate":0.424242,"avgChangeRate":0.11624},{"month":3,"riseRate":0.294118,"avgChangeRate":0.093297},{"month":4,"riseRate":0.30303,"avgChangeRate":0.087332},{"month":5,"riseRate":0.454545,"avgChangeRate":0.014168},{"month":6,"riseRate":0.5,"avgChangeRate":0.037176},{"month":7,"riseRate":0.294118,"avgChangeRate":0.019627},{"month":8,"riseRate":0.176471,"avgChangeRate":-0.034646},{"month":9,"riseRate":0.242424,"avgChangeRate":-0.048197},{"month":10,"riseRate":0.34375,"avgChangeRate":0.029107},{"month":11,"riseRate":0.28125,"avgChangeRate":-0.01241},{"month":12,"riseRate":0.212121,"avgChangeRate":-0.037096}],"exchange":"SEHK","name":"玮俊生物科技","nameEN":"WAI CHUN BIOTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"玮俊生物科技(00660)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供玮俊生物科技(00660)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"玮俊生物科技,00660,玮俊生物科技股票,玮俊生物科技股票老虎,玮俊生物科技股票老虎国际,玮俊生物科技行情,玮俊生物科技股票行情,玮俊生物科技股价,玮俊生物科技股市,玮俊生物科技股票价格,玮俊生物科技股票交易,玮俊生物科技股票购买,玮俊生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"玮俊生物科技(00660)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供玮俊生物科技(00660)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}